BTSGU
BrightSpring Health Services, Inc.
NASDAQ · Healthcare · Medical - Healthcare Information Services · US
$226.20
+0.56%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 15.3B | 12.9B | 11.3B | 8.8B | 7.7B |
| Cost of Revenue | 13.3B | 11.4B | 9.7B | 7.4B | 6.4B |
| Gross Profit | 1.9B | 1.5B | 1.6B | 1.4B | 1.4B |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | 1.4B | 1.2B | 1.4B | 1.3B | 1.1B |
| General & Admin Expense | 358.1M | — | — | — | — |
| Selling & Marketing Expense | — | — | — | — | — |
| Other Expenses | — | — | — | — | 40.9M |
| Total Operating Expenses | 1.4B | 1.2B | 1.4B | 1.3B | 1.2B |
| Cost and Expenses | 14.7B | 12.6B | 11.1B | 8.7B | 7.5B |
| Operating Income (EBIT) | 550.7M | 295.3M | 206.4M | 147.2M | 187.8M |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | 145.1M | 157.3M | 228.4M | 324.6M | 233.6M |
| Net Interest Income | (145.1M) | (157.3M) | (228.4M) | (324.6M) | (233.6M) |
| Other Non-Op Income/Expense | (175.4M) | (157.3M) | (241.1M) | (324.6M) | (233.6M) |
| Non-Operating Income (excl Interest) | — | — | 12.7M | — | — |
| EBT (Pre-Tax Income) | 375.4M | 137.9M | (34.7M) | (177.4M) | (45.8M) |
| Income Tax Expense | 64.1M | 33.1M | (14.2M) | (20.6M) | 8.5M |
| Bottom Line | |||||
| Net Income | 338.3M | 190.7M | (18.1M) | (154.6M) | (53.9M) |
| Earnings from Cont. Ops | 311.2M | 104.8M | (20.5M) | (156.8M) | (54.2M) |
| Earnings from Discont. Ops | 27.3M | 84.3M | — | — | — |
| Bottom Line Net Income | 338.3M | 190.7M | (18.1M) | (154.6M) | (53.9M) |
| Per Share | |||||
| Basic EPS | $1.64 | $0.94 | ($0.09) | ($0.90) | ($0.31) |
| Diluted EPS | $1.53 | $0.87 | ($0.09) | ($0.90) | ($0.31) |
| Revenue Per Share | $73.67 | $63.74 | $58.38 | $51.56 | $45.10 |
| Shares | |||||
| Basic Shares Outstanding | 207.0M | 202.6M | 193.0M | 171.2M | 171.2M |
| Diluted Shares Outstanding | 220.2M | 219.8M | 193.0M | 171.2M | 171.2M |
| Profitability Metrics | |||||
| EBITDA | 709.2M | 459.5M | 398.1M | 349.5M | 391.8M |
| D&A | 158.4M | 164.3M | 204.5M | 202.3M | 204.0M |
| EBIT | 550.7M | 295.3M | 193.6M | 147.2M | 187.8M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Sep 1, 2026